Latest KFF Health News Stories
How ERs Fail Patients With Addiction: One Patient’s Tragic Death
Two intractable failings of the U.S. health care system — addiction treatment and medical costs — come to a head in the ER, where patients desperate for addiction treatment arrive, only to find the facility may not be equipped to deal with substance use or, if they are, treatment is prohibitively expensive.
Dying Patients With Rare Diseases Struggle to Get Experimental Therapies
When patients with common terminal illnesses such as cancer seek permission for compassionate use of therapies in the testing stage, their requests often are approved. But those with more unusual illnesses say drug companies are rarely willing to provide access.
Why We May Never Know Whether the $56,000-a-Year Alzheimer’s Drug Actually Works
It could take years for follow-up studies to prove Aduhelm slows the disease — or doesn’t. Meanwhile, its maker will profit.
Effort to Decipher Hospital Prices Yields Key Finding: Don’t Try It at Home
Your dutiful columnist tried to make use of a federal “transparency” rule to compare the prices of common medical procedures in two California health care systems. It was a futile exercise.
Paying Billions for Controversial Alzheimer’s Drug? How About Funding This Instead?
Aduhelm, approved by the Food and Drug Administration last month despite questions about its efficacy, could be prescribed to at least 1 million patients a year, for a price tag of about $56 billion. Experts suggest there might be better ways to spend that money.
‘An Arm and a Leg’: Tips for Fighting Medical Bills from ProPublica’s Marshall Allen
Veteran health journalist Marshall Allen has been exposing health care grifters for years. Now he’s written a book about how to fight them. Host Dan Weissmann spoke with Allen about some of the best tips from “Never Pay the First Bill: And Other Ways to Fight the Health Care System and Win.”
Hospital Prices Must Now Be Transparent. For Many Consumers, They’re Still Anyone’s Guess.
A Trump administration rule mandating that hospitals disclose true prices on their websites took effect this year. But compliance is spotty and even when the data is public, it’s hard to find and understand.
Desperate for Home Care, Seniors Often Wait Months With Workers in Short Supply
The covid pandemic and President Joe Biden’s agenda — a planned $400 billion infusion of support — have focused national attention on the need to expand home- and community-based long-term care services designed to keep people out of nursing homes. But the need far outpaces the staffing.
A Hospital Charged $722.50 to Push Medicine Through an IV. Twice.
A college student never got an answer for what caused her intense pain, but she did get a bill that totaled $18,736 for an ER visit. She and her mom, a nurse practitioner, fought to understand all the charges.
KHN’s ‘What the Health?’: How to Expand Health Coverage
Democrats in Congress and the states are devising strategies to expand health coverage — through the Affordable Care Act, Medicare, Medicaid and a “public option.” But progress remains halting, at best. Meanwhile, lawmakers in Washington may have to agree on how to control prescription drug prices if they wish to finance their coverage initiatives. Alice Miranda Ollstein of Politico, Tami Luhby of CNN and Shefali Luthra of The 19th join KHN’s Julie Rovner to discuss these issues and more. Also, Rovner interviews Michelle Andrews, who reported and wrote last month’s KHN-NPR “Bill of the Month” episode about a very expensive sleep study.
In a Murky Sea of Mental Health Apps, Consumers Left Adrift
Venture capitalists have poured billions into the digital mental health space, sensing an area of unmet demand that is ripe for disruption. The problem for consumers is separating the apps that might help from those that offer little more than distraction — or could actually do harm.
Montana Tribe Welcomes Back Tourists After Risky Shutdown Pays Off
When the Blackfeet tribe shut down the roads leading to the eastern side of Glacier National Park, businesses worried for their future. But it worked, and with one of the nation’s highest covid vaccination rates, the reservation has reopened to visitors.
Pandemia eleva el número de beneficiarios de Medicaid a más de 80 millones
Las últimas cifras de inscripción al Medicaid muestran que creció de 71,3 millones de miembros en febrero de 2020, cuando la pandemia comenzaba en los Estados Unidos, a 80,5 millones en enero, según un análisis de KFF de datos federales.
Pandemic Swells Medicaid Enrollment to 80 Million People, a ‘High-Water Mark’
More than 80 million Americans with low incomes were receiving health coverage through the federal-state program in January. The program now covers nearly 1 in 4 people nationwide.
Device Makers Have Funneled Billions to Orthopedic Surgeons Who Use Their Products
Federal officials say that some of the money changing hands has corrupted doctors and endangered patients.
In Alleged Health Care ‘Money Grab,’ Nation’s Largest Hospital Chain Cashes In on Trauma Centers
HCA charges patients an “activation fee” of up to $50,000 for trauma teams at centers located in half its 179 hospitals — and they often don’t need trauma care, an analysis of insurance claims data shows.
‘An Arm and a Leg’: When Your Insurance Company Says No, How to Ask for a Yes
Health care insiders get surprise medical bills, too. One of them shares tips for writing an insurance appeal.
Colorado está a punto de aprobar una ley para que los trabajadores del campo puedan acceder a atención médica, algo que muchos empleadores al parecer no permiten.
Farmworkers Recall Mistreatment as Colorado Aims to Guarantee Medical Access
Agricultural workers living in employer-owned housing can have trouble getting health care. It’s symptomatic of bigger gaps in worker protections that the pandemic spotlighted, say proponents of a newly passed Colorado bill for farmworker rights.
Doctor on Call? Lawmakers Debate How Much to Pay for Phone Appointments
Phone visits became an option for many Medicare and Medicaid patients during the pandemic. Now policymakers are deciding whether they’re worth the money.
